103 | THE 6-(METHYLSULFINYL)HEXYL ISOTHIOCYANATE AS NEUROPROTECTIVE AGENT IN A MURINE MODEL OF ALZHEIMER'S DISEASE 1)Sita G. 2)Morroni F. 3)Graziosi A. 4)Tarozzi A. 5)Hrelia P. |
127 | GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 1)Balbi M.. 2)Rebosio C.. 3)Brullo C.. 4)Prickaerts J.. 5)Arancio O.. 6)Bruno O.. 7)Calcagno E.. 8)Ricciarelli R.. 9)Fedele E.. |
154 | EFFECT OF PALMYTOILETHANOLAMIDE IN 3XTG-AD ASTROCYTES AS AN IN VITRO MODEL OF ALZHEIMER'S DISEASE 1)Bronzuoli MR. 2)Facchinetti R. 3)Letizia A. 4)Cassano T. 5)Steardo L. 6)Scuderi C. |
161 | BEHAVIOURAL AND NEUROPATHOLOGICAL EFFECTS OF INTRANASAL INSULIN TREATMENT IN A TRIPLE-TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE (3×TG-AD) 1)Calcagnini S. 2)Barone E. 3)Lavecchia AM. 4)Lancioni M. 5)Meconi A. 6)Perluigi M. 7)Cassano T. |
246 | EFFECT OF ULTRAMICRONIZED-PALMYTOILETHANOLAMIDE ON ASTROCYTE DYSFUNCTION IN A TRIPLE TRANSGENIC MODEL OF ALZHEIMER'S DISEASE 1)Facchinetti R.. 2)Bronzuoli MR. 3)Letizia A.. 4)Cassano T.. 5)Steardo L.. 6)Scuderi C.. |
250 | cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 1)Fedele E. 2)Rebosio C. 3)Balbi M. 4)Calcagno E. 5)Gulisano W. 6)Arancio O. 7)Palmeri A. 8)Puzzo D. 9)Ricciarelli R. |
392 | NEUROPROTECTIVE EFFECTS OF THE NOVEL MARINE CAROTENOID FUCOXANTHIN IN HUMAN NEURONAL SH-SY5Y CELLS 1)Pruccoli L. 2)Sita G. 3)Morroni F. 4)Hrelia P. 5)Tarozzi A. |
422 | THE CONTRIBUTION OF MICROGLIA TO THE ENHANCED SYNAPTIC ACTIVITY THAT PRECEDES AB-INDUCED NEURONAL DEATH 1)Spampinato SF. 2)Merlo S. 3)Beneventano M. 4)Sortino MA. |